Lv4
490 积分 2025-07-06 加入
Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
8天前
已完结
Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
8天前
已完结
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
8天前
已完结
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
8天前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
8天前
已完结
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
8天前
已完结
Efficacy of beinaglutide in the treatment of hepatic steatosis in type 2 diabetes patients with nonalcoholic fatty liver disease: A randomized, open-label, controlled trial
12天前
已完结
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial
12天前
已完结
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
12天前
已完结
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
12天前
已完结
皖公网安备34019202002308
